| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEOGENOMICS INC | President Advanced Diagnostics | Common Stock | 129K | $1.93M | $14.96 | Feb 23, 2024 | Direct |
| NEOGENOMICS INC | President Advanced Diagnostics | Performance Stock Unit | 25.3K | $379K | $14.96 | Feb 23, 2024 | Direct |
| NEOGENOMICS INC | President Advanced Diagnostics | Restricted Stock Unit | 25.3K | $379K | $14.96 | Feb 23, 2024 | Direct |
| NEOGENOMICS INC | President Advanced Diagnostics | Stock Option (Right to Buy) | 42.3K | Feb 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NEO | NEOGENOMICS INC | Feb 23, 2024 | 3 | $0 | 4 | Feb 27, 2024 | President Advanced Diagnostics |
| NEO | NEOGENOMICS INC | Jun 1, 2023 | 1 | $0 | 4 | Jun 2, 2023 | President Advanced Diagnostics |
| NEO | NEOGENOMICS INC | May 11, 2023 | 3 | $0 | 4 | May 15, 2023 | President Advanced Diagnostics |
| NEO | NEOGENOMICS INC | Dec 31, 2022 | 1 | $1.58K | 5 | Feb 1, 2023 | President, Pharma Services |
| NEO | NEOGENOMICS INC | Jun 1, 2022 | 2 | $0 | 4 | Jun 2, 2022 | President and CCO, Inivata |
| NEO | NEOGENOMICS INC | May 23, 2022 | 0 | $0 | 3 | Jun 2, 2022 | President and CCO, Inivata |